Tapewire

Nasdaq · USD

SLDB

Solid Biosciences Inc.

Export transactions ↓
Tapewire entity
4915
SEC CIK
0001707502
Parsed reports
381

Last 12 months

Inside the activity.

0 purchase rows · 28 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202504
Jan 202603
Feb 2026020
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 06, 2025 Filed Jan 7, 2025 22:28 UTC
SMITH IAN FDirector
GrantStock Option (Right to Buy) · Derivative 22,148 $0.00 Strike: $4.10 $0.00
Disclosure

SEC source: 0000950170-25-003052 · ownership.xml · derivative · entry 3

SMITH IAN F · CIK 0001197032 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,148

Underlying: Common Stock · 22,148 shares

Expires 2035-01-06

F3 · derivative.exercise_date: The Smith RSUs (as defined in footnote 4) and this option (together with the Smith RSUs, the "Smith Equity Awards") were granted on January 6, 2025 ("the Grant Date") and vest in equal quarterly installments with the first installment vesting three months from the Grant Date and the final installment vesting date being the date that is 12 months from the Grant Date; provided that in the event of the early termination of the Second Amendment to Executive Chair Agreement between the Issuer and the reporting person (the "Smith Agreement") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the Smith Equity Awards shall accelerate in full.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 22:29 UTC
Ganot IlanDirector
Exercise / conversionRestricted Stock Units · Derivative 2,994 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-003054 · ownership.xml · derivative · entry 5

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Wife

Disclosed balance after: 5,988

Underlying: Common Stock · 2,994 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert to common stock on a one-for-one basis.

F5 · derivative.exercise_date: On January 3, 2023 (the "Grant Date"), Ms. Ganot was granted 11,975 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date.

F5 · derivative.expiration_date: On January 3, 2023 (the "Grant Date"), Ms. Ganot was granted 11,975 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 22:29 UTC
Ganot IlanDirector
Exercise / conversionCommon Stock 2,994 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-25-003054 · ownership.xml · nonDerivative · entry 1

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Wife

Disclosed balance after: 12,501

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert to common stock on a one-for-one basis.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 22:28 UTC
SMITH IAN FDirector
Exercise / conversionRestricted Stock Units · Derivative 3,255 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-003052 · ownership.xml · derivative · entry 2

SMITH IAN F · CIK 0001197032 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,255 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert to common stock on a one-for-one basis.

F2 · derivative.exercise_date: The restricted stock units were granted on January 3, 2024 and vested in equal quarterly installments beginning three months from the date of grant, with the final installment vesting 12 months from the date of grant.

F2 · derivative.expiration_date: The restricted stock units were granted on January 3, 2024 and vested in equal quarterly installments beginning three months from the date of grant, with the final installment vesting 12 months from the date of grant.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 22:28 UTC
SMITH IAN FDirector
Exercise / conversionCommon Stock 3,255 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-25-003052 · ownership.xml · nonDerivative · entry 1

SMITH IAN F · CIK 0001197032 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 112,972

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert to common stock on a one-for-one basis.

Read SEC document
December 03, 2024 Filed Dec 4, 2024 22:34 UTC
Hanrahan JessieChief Regulatory Officer
SaleCommon Stock 4,610 $5.60 $25,822.45
Disclosure

SEC source: 0000950170-24-133369 · ownership.xml · nonDerivative · entry 2

Hanrahan Jessie · CIK 0001954826 · Chief Regulatory Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,235

F2 · shares: This sale was made to cover withholding taxes following the vesting of the previously granted RSUs. The sale does not represent a discretionary trade made by Dr. Hanrahan.

Read SEC document
December 03, 2024 Filed Dec 4, 2024 22:27 UTC
Cumbo AlexanderDirector · President and CEO
SaleCommon Stock 11,114 $5.60 $62,236.18
Disclosure

SEC source: 0000950170-24-133360 · ownership.xml · nonDerivative · entry 2

Cumbo Alexander · CIK 0001685994 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,484

F3 · shares: This sale was made to cover withholding taxes following the vesting of the previously granted RSUs. The sale does not represent a discretionary trade made by Mr. Cumbo.

Read SEC document
December 03, 2024 Filed Dec 4, 2024 22:04 UTC
Howton David TChief Operating Officer
SaleCommon Stock 5,072 $5.60 $28,396.10
Disclosure

SEC source: 0000950170-24-133340 · ownership.xml · nonDerivative · entry 2

Howton David T · CIK 0001529297 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,663

F2 · shares: This sale was made to cover withholding taxes following the vesting of the previously granted RSUs. The sale does not represent a discretionary trade made by Mr. Howton.

Read SEC document
December 03, 2024 Filed Dec 4, 2024 21:42 UTC
Herzich PaulChief Technology Officer
SaleCommon Stock 2,777 $5.60 $15,550.64
Disclosure

SEC source: 0000950170-24-133317 · ownership.xml · nonDerivative · entry 2

Herzich Paul · CIK 0001954991 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,182

F3 · shares: This sale was made to cover withholding taxes following the vesting of the previously granted RSUs. The sale does not represent a discretionary trade made by Dr. Herzich.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 22:34 UTC
Hanrahan JessieChief Regulatory Officer
Exercise / conversionRestricted Stock Units · Derivative 11,862 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-133369 · ownership.xml · derivative · entry 3

Hanrahan Jessie · CIK 0001954826 · Chief Regulatory Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,725

Underlying: Common Stock · 11,862 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs").

F3 · derivative.exercise_date: The RSUs were granted on December 2, 2022 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.

F3 · derivative.expiration_date: The RSUs were granted on December 2, 2022 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 22:34 UTC
Hanrahan JessieChief Regulatory Officer
Exercise / conversionCommon Stock 11,862 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-24-133369 · ownership.xml · nonDerivative · entry 1

Hanrahan Jessie · CIK 0001954826 · Chief Regulatory Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,845

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs").

Read SEC document
December 02, 2024 Filed Dec 4, 2024 22:27 UTC
Cumbo AlexanderDirector · President and CEO
Exercise / conversionRestricted Stock Units · Derivative 28,612 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-133360 · ownership.xml · derivative · entry 3

Cumbo Alexander · CIK 0001685994 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,225

Underlying: Common Stock · 28,612 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs").

F4 · derivative.exercise_date: The RSUs were granted on December 2, 2022 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.

F4 · derivative.expiration_date: The RSUs were granted on December 2, 2022 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 22:27 UTC
Cumbo AlexanderDirector · President and CEO
Exercise / conversionCommon Stock 28,612 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-24-133360 · ownership.xml · nonDerivative · entry 1

Cumbo Alexander · CIK 0001685994 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,598

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs").

F2 · balance_after: Includes 3,547 shares of common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on May 31, 2024.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 22:04 UTC
Howton David TChief Operating Officer
Exercise / conversionRestricted Stock Units · Derivative 13,051 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-133340 · ownership.xml · derivative · entry 3

Howton David T · CIK 0001529297 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,103

Underlying: Common Stock · 13,051 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs").

F3 · derivative.exercise_date: The RSUs were granted on December 2, 2022 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.

F3 · derivative.expiration_date: The RSUs were granted on December 2, 2022 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 22:04 UTC
Howton David TChief Operating Officer
Exercise / conversionCommon Stock 13,051 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-24-133340 · ownership.xml · nonDerivative · entry 1

Howton David T · CIK 0001529297 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,735

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs").

Read SEC document
December 02, 2024 Filed Dec 4, 2024 21:42 UTC
Herzich PaulChief Technology Officer
Exercise / conversionRestricted Stock Units · Derivative 7,239 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-133317 · ownership.xml · derivative · entry 3

Herzich Paul · CIK 0001954991 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,478

Underlying: Common Stock · 7,239 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs").

F4 · derivative.exercise_date: The RSUs were granted on December 2, 2022 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.

F4 · derivative.expiration_date: The RSUs were granted on December 2, 2022 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 21:42 UTC
Herzich PaulChief Technology Officer
Exercise / conversionCommon Stock 7,239 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-24-133317 · ownership.xml · nonDerivative · entry 1

Herzich Paul · CIK 0001954991 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,959

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs").

F2 · balance_after: Includes 1,698 shares of common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on May 31, 2024.

Read SEC document
October 21, 2024 Filed Oct 22, 2024 20:05 UTC
Brooks GabrielChief Medical Officer
SaleCommon Stock 2,923 $6.50 $18,999.50
Disclosure

SEC source: 0000950170-24-116246 · ownership.xml · nonDerivative · entry 2

Brooks Gabriel · CIK 0001997809 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,979

F3 · shares: This sale was made to cover withholding taxes following the vesting of the previously granted RSUs.

Read SEC document
October 18, 2024 Filed Oct 22, 2024 20:05 UTC
Brooks GabrielChief Medical Officer
Exercise / conversionRestricted Stock Units · Derivative 9,750 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-116246 · ownership.xml · derivative · entry 3

Brooks Gabriel · CIK 0001997809 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,250

Underlying: Common Stock · 9,750 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.

F4 · derivative.exercise_date: The RSUs were granted on October 18, 2023 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.

F4 · derivative.expiration_date: The RSUs were granted on October 18, 2023 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.

Read SEC document
October 18, 2024 Filed Oct 22, 2024 20:05 UTC
Brooks GabrielChief Medical Officer
Exercise / conversionCommon Stock 9,750 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-24-116246 · ownership.xml · nonDerivative · entry 1

Brooks Gabriel · CIK 0001997809 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,902

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.

F2 · balance_after: Includes 4,152 shares of common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on May 31, 2024.

Read SEC document
October 03, 2024 Filed Oct 4, 2024 20:05 UTC
SMITH IAN FDirector
Exercise / conversionRestricted Stock Units · Derivative 3,255 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-112898 · ownership.xml · derivative · entry 2

SMITH IAN F · CIK 0001197032 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,255

Underlying: Common Stock · 3,255 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: The restricted stock units were granted on January 3, 2024 (the "Grant Date") and vest in equal quarterly installments beginning three months from the Grant Date, with the final installment vesting the date that is 12 months from the Grant Date; provided that in the event of early termination of the Second Amendment to the Executive Chair Agreement between the Issuer and the reporting person (the "Smith Agreement") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the restricted stock units shall accelerate in full.

F2 · derivative.expiration_date: The restricted stock units were granted on January 3, 2024 (the "Grant Date") and vest in equal quarterly installments beginning three months from the Grant Date, with the final installment vesting the date that is 12 months from the Grant Date; provided that in the event of early termination of the Second Amendment to the Executive Chair Agreement between the Issuer and the reporting person (the "Smith Agreement") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the restricted stock units shall accelerate in full.

Read SEC document
October 03, 2024 Filed Oct 4, 2024 20:05 UTC
SMITH IAN FDirector
Exercise / conversionCommon Stock 3,255 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-24-112898 · ownership.xml · nonDerivative · entry 1

SMITH IAN F · CIK 0001197032 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 109,717

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
July 03, 2024 Filed Jul 5, 2024 20:05 UTC
SMITH IAN FDirector
Exercise / conversionRestricted Stock Units · Derivative 3,255 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-081866 · ownership.xml · derivative · entry 2

SMITH IAN F · CIK 0001197032 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,510

Underlying: Common Stock · 3,255 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: The restricted stock units were granted on January 3, 2024 (the "Grant Date") and vest in equal quarterly installments beginning three months from the Grant Date, with the final installment vesting the date that is 12 months from the Grant Date; provided that in the event of early termination of the Second Amendment to the Executive Chair Agreement between the Issuer and the reporting person (the "Smith Agreement") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the restricted stock units shall accelerate in full.

F2 · derivative.expiration_date: The restricted stock units were granted on January 3, 2024 (the "Grant Date") and vest in equal quarterly installments beginning three months from the Grant Date, with the final installment vesting the date that is 12 months from the Grant Date; provided that in the event of early termination of the Second Amendment to the Executive Chair Agreement between the Issuer and the reporting person (the "Smith Agreement") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the restricted stock units shall accelerate in full.

Read SEC document
July 03, 2024 Filed Jul 5, 2024 20:05 UTC
SMITH IAN FDirector
Exercise / conversionCommon Stock 3,255 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-24-081866 · ownership.xml · nonDerivative · entry 1

SMITH IAN F · CIK 0001197032 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 106,462

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
June 11, 2024 Filed Jun 13, 2024 20:05 UTC
Ganot IlanDirector
GrantDirector Stock Option (Right to Buy) · Derivative 34,400 $0.00 Strike: $7.51 $0.00
Disclosure

SEC source: 0000950170-24-072992 · ownership.xml · derivative · entry 1

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,400

Underlying: Common Stock · 34,400 shares

Expires 2034-06-11

F1 · derivative.exercise_date: This option was granted on June 11, 2024 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.

Read SEC document
June 11, 2024 Filed Jun 13, 2024 20:13 UTC GrantDirector Stock Option (Right to Buy) · Derivative 34,400 $0.00 Strike: $7.51 $0.00
Disclosure

SEC source: 0000950170-24-073013 · ownership.xml · derivative · entry 1

Keresty Georgia · CIK 0001773532 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,400

Underlying: Common Stock · 34,400 shares

Expires 2034-06-11

F1 · derivative.exercise_date: This option was granted on June 11, 2024 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.

Read SEC document
June 11, 2024 Filed Jun 13, 2024 20:11 UTC
SMITH IAN FDirector
GrantDirector Stock Option (Right to Buy) · Derivative 34,400 $0.00 Strike: $7.51 $0.00
Disclosure

SEC source: 0000950170-24-073006 · ownership.xml · derivative · entry 1

SMITH IAN F · CIK 0001197032 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,400

Underlying: Common Stock · 34,400 shares

Expires 2034-06-11

F1 · derivative.exercise_date: This option was granted on June 11, 2024 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.

Read SEC document
June 11, 2024 Filed Jun 13, 2024 20:10 UTC GrantDirector Stock Option (Right to Buy) · Derivative 34,400 $0.00 Strike: $7.51 $0.00
Disclosure

SEC source: 0000950170-24-073003 · ownership.xml · derivative · entry 1

Sullivan Lynne Marie · CIK 0001727640 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,400

Underlying: Common Stock · 34,400 shares

Expires 2034-06-11

F1 · derivative.exercise_date: This option was granted on June 11, 2024 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.

Read SEC document
June 11, 2024 Filed Jun 13, 2024 20:10 UTC GrantDirector Stock Option (Right to Buy) · Derivative 34,400 $0.00 Strike: $7.51 $0.00
Disclosure

SEC source: 0000950170-24-073000 · ownership.xml · derivative · entry 1

Freed Martin I · CIK 0001676653 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,400

Underlying: Common Stock · 34,400 shares

Expires 2034-06-11

F1 · derivative.exercise_date: This option was granted on June 11, 2024 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.

Read SEC document
June 11, 2024 Filed Jun 13, 2024 20:08 UTC GrantDirector Stock Option (Right to Buy) · Derivative 34,400 $0.00 Strike: $7.51 $0.00
Disclosure

SEC source: 0000950170-24-072998 · ownership.xml · derivative · entry 1

Nagendran Sukumar · CIK 0001665124 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,400

Underlying: Common Stock · 34,400 shares

Expires 2034-06-11

F1 · derivative.exercise_date: This option was granted on June 11, 2024 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.

Read SEC document
June 11, 2024 Filed Jun 13, 2024 20:06 UTC
Kahn ClareDirector
GrantDirector Stock Option (Right to Buy) · Derivative 34,400 $0.00 Strike: $7.51 $0.00
Disclosure

SEC source: 0000950170-24-072996 · ownership.xml · derivative · entry 1

Kahn Clare · CIK 0001849236 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,400

Underlying: Common Stock · 34,400 shares

Expires 2034-06-11

F1 · derivative.exercise_date: This option was granted on June 11, 2024 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.

Read SEC document
June 11, 2024 Filed Nov 19, 2024 21:20 UTC
PERCEPTIVE ADVISORS LLCDirector · 10% owner
EDELMAN JOSEPHDirector · 10% owner
GrantDirector Stock Option (Right to Buy) · Derivative 34,400 $0.00 Strike: $7.51 $0.00
Disclosure

SEC source: 0001062993-24-019352 · form4.xml · derivative · entry 1

PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · Director · 10% owner

EDELMAN JOSEPH · CIK 0001164426 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnotes

Disclosed balance after: 34,400

Underlying: Common Stock · 34,400 shares

Expires 2034-06-11

F1 · derivative.exercise_date: This option was granted on June 11, 2024 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.

F2 · ownership.nature: Consists of options to purchase shares of the Issuer's common stock awarded to Adam Stone in connection with his role as a member of the Issuer's Board of Directors. Mr. Stone is the Chief Investment Officer of Perceptive Advisors, LLC (the "Advisor"). The Advisor may be deemed to have an indirect pecuniary interest in the options to purchase common stock of the Issuer reported herein because the Advisor has the right to receive the director compensation provided in respect of Mr. Stone's board service through a partial management fee offset.

F3 · ownership.nature: Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.

Read SEC document
June 11, 2024 Filed Nov 19, 2024 21:20 UTC GrantDirector Stock Option (Right to Buy) · Derivative 34,400 $0.00 Strike: $7.51 $0.00
Disclosure

SEC source: 0001062993-24-019353 · form4.xml · derivative · entry 1

Stone Adam Leo · CIK 0001727440 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,400

Underlying: Common Stock · 34,400 shares

Expires 2034-06-11

F1 · derivative.exercise_date: This option was granted on June 11, 2024 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.

Read SEC document
June 07, 2024 Filed Jun 11, 2024 18:15 UTC
Kahn ClareDirector
PurchaseCommon Stock 1,100 $7.67 $8,441.62
Disclosure

SEC source: 0000950170-24-071765 · ownership.xml · nonDerivative · entry 1

Kahn Clare · CIK 0001849236 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,100

Read SEC document
May 02, 2024 Filed May 6, 2024 22:48 UTC
Ganot IlanDirector
Exercise / conversionRestricted Stock Units · Derivative 1,553 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-053774 · ownership.xml · derivative · entry 5

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Wife

Disclosed balance after: 0

Underlying: Common Stock · 1,553 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F5 · derivative.exercise_date: The restricted stock units were granted on May 2, 2022 and vested in two equal installments on May 2, 2023 and May 2, 2024.

F5 · derivative.expiration_date: The restricted stock units were granted on May 2, 2022 and vested in two equal installments on May 2, 2023 and May 2, 2024.

Read SEC document
May 02, 2024 Filed May 6, 2024 22:48 UTC
Ganot IlanDirector
SaleCommon Stock 462 $10.33 $4,772.46
Disclosure

SEC source: 0000950170-24-053774 · ownership.xml · nonDerivative · entry 2

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Wife

Disclosed balance after: 9,507

F2 · shares: This sale was made to cover withholding taxes following the vesting of previously granted restricted stock units. This sale does not represent a discretionary trade by Ms. Ganot.

Read SEC document
May 02, 2024 Filed May 6, 2024 22:48 UTC
Ganot IlanDirector
Exercise / conversionCommon Stock 1,553 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-24-053774 · ownership.xml · nonDerivative · entry 1

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Wife

Disclosed balance after: 9,969

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
April 03, 2024 Filed Apr 5, 2024 20:45 UTC
SMITH IAN FDirector
Exercise / conversionRestricted Stock Units · Derivative 3,256 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-042322 · ownership.xml · derivative · entry 2

SMITH IAN F · CIK 0001197032 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,765

Underlying: Common Stock · 3,256 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: The restricted stock units were granted on January 3, 2024 (the "Grant Date") and vest in equal quarterly installments beginning three months from the Grant Date, with the final installment vesting the date that is 12 months from the Grant Date; provided that in the event of early termination of the Second Amendment to the Executive Chair Agreement between the Issuer and the reporting person (the "Smith Agreement") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the restricted stock units shall accelerate in full.

F2 · derivative.expiration_date: The restricted stock units were granted on January 3, 2024 (the "Grant Date") and vest in equal quarterly installments beginning three months from the Grant Date, with the final installment vesting the date that is 12 months from the Grant Date; provided that in the event of early termination of the Second Amendment to the Executive Chair Agreement between the Issuer and the reporting person (the "Smith Agreement") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the restricted stock units shall accelerate in full.

Read SEC document
April 03, 2024 Filed Apr 5, 2024 20:45 UTC
SMITH IAN FDirector
Exercise / conversionCommon Stock 3,256 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-24-042322 · ownership.xml · nonDerivative · entry 1

SMITH IAN F · CIK 0001197032 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 103,207

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
February 13, 2024 Filed Feb 16, 2024 15:50 UTC
Ganot IlanDirector
GrantRestricted Stock Units · Derivative 19,444 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-016180 · ownership.xml · derivative · entry 1

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Wife

Disclosed balance after: 19,444

Underlying: Common Stock · 19,444 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock (the "RSUs").

F2 · derivative.exercise_date: The RSUs were granted on the February 13, 2024 and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.

F2 · derivative.expiration_date: The RSUs were granted on the February 13, 2024 and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.

Read SEC document
February 13, 2024 Filed Feb 16, 2024 17:03 UTC
Hanrahan JessieChief Regulatory Officer
GrantRestricted Stock Units · Derivative 32,500 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-016220 · ownership.xml · derivative · entry 2

Hanrahan Jessie · CIK 0001954826 · Chief Regulatory Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,500

Underlying: Common Stock · 32,500 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock (the "RSUs").

F3 · derivative.exercise_date: The RSUs were granted on the Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.

F3 · derivative.expiration_date: The RSUs were granted on the Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.

Read SEC document
February 13, 2024 Filed Feb 16, 2024 17:03 UTC
Hanrahan JessieChief Regulatory Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 65,000 $0.00 Strike: $7.85 $0.00
Disclosure

SEC source: 0000950170-24-016220 · ownership.xml · derivative · entry 1

Hanrahan Jessie · CIK 0001954826 · Chief Regulatory Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,000

Underlying: Common Stock · 65,000 shares

Expires 2034-02-13

F1 · derivative.exercise_date: This option was granted on February 13, 2024 (the "Grant Date") and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the Grant Date and 2.0833% of the original number of shares monthly thereafter until the fourth such anniversary.

Read SEC document
February 13, 2024 Filed Feb 16, 2024 17:01 UTC
Cumbo AlexanderDirector · President and CEO
GrantRestricted Stock Units · Derivative 120,125 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-016219 · ownership.xml · derivative · entry 2

Cumbo Alexander · CIK 0001685994 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,125

Underlying: Common Stock · 120,125 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock (the "RSUs").

F3 · derivative.exercise_date: The RSUs were granted on the Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.

F3 · derivative.expiration_date: The RSUs were granted on the Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.

Read SEC document
February 13, 2024 Filed Feb 16, 2024 17:01 UTC
Cumbo AlexanderDirector · President and CEO
GrantEmployee Stock Option (Right to Buy) · Derivative 240,250 $0.00 Strike: $7.85 $0.00
Disclosure

SEC source: 0000950170-24-016219 · ownership.xml · derivative · entry 1

Cumbo Alexander · CIK 0001685994 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 240,250

Underlying: Common Stock · 240,250 shares

Expires 2034-02-13

F1 · derivative.exercise_date: This option was granted on February 13, 2024 (the "Grant Date") and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the Grant Date and 2.0833% of the original number of shares monthly thereafter until the fourth such anniversary.

Read SEC document
February 13, 2024 Filed Feb 16, 2024 16:56 UTC
Brooks GabrielChief Medical Officer
GrantRestricted Stock Units · Derivative 43,750 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-016216 · ownership.xml · derivative · entry 2

Brooks Gabriel · CIK 0001997809 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,750

Underlying: Common Stock · 43,750 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock (the "RSUs").

F3 · derivative.exercise_date: The RSUs were granted on the Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.

F3 · derivative.expiration_date: The RSUs were granted on the Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.

Read SEC document
February 13, 2024 Filed Feb 16, 2024 16:56 UTC
Brooks GabrielChief Medical Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 87,500 $0.00 Strike: $7.85 $0.00
Disclosure

SEC source: 0000950170-24-016216 · ownership.xml · derivative · entry 1

Brooks Gabriel · CIK 0001997809 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,500

Underlying: Common Stock · 87,500 shares

Expires 2034-02-13

F1 · derivative.exercise_date: This option was granted on February 13, 2024 (the "Grant Date") and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the Grant Date and 2.0833% of the original number of shares monthly thereafter until the fourth such anniversary.

Read SEC document
February 13, 2024 Filed Feb 16, 2024 16:45 UTC
Tan KevinCFO & Treasurer
GrantRestricted Stock Units · Derivative 42,500 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-016213 · ownership.xml · derivative · entry 2

Tan Kevin · CIK 0001884056 · CFO & Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,500

Underlying: Common Stock · 42,500 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock (the "RSUs").

F3 · derivative.exercise_date: The RSUs were granted on the Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.

F3 · derivative.expiration_date: The RSUs were granted on the Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.

Read SEC document
February 13, 2024 Filed Feb 16, 2024 16:45 UTC
Tan KevinCFO & Treasurer
GrantEmployee Stock Option (Right to Buy) · Derivative 85,000 $0.00 Strike: $7.85 $0.00
Disclosure

SEC source: 0000950170-24-016213 · ownership.xml · derivative · entry 1

Tan Kevin · CIK 0001884056 · CFO & Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 85,000

Underlying: Common Stock · 85,000 shares

Expires 2034-02-13

F1 · derivative.exercise_date: This option was granted on February 13, 2024 (the "Grant Date") and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the Grant Date and 2.0833% of the original number of shares monthly thereafter until the fourth such anniversary.

Read SEC document
February 13, 2024 Filed Feb 16, 2024 16:28 UTC
Howton David TChief Operating Officer
GrantRestricted Stock Units · Derivative 58,750 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-016193 · ownership.xml · derivative · entry 2

Howton David T · CIK 0001529297 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,750

Underlying: Common Stock · 58,750 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock (the "RSUs").

F3 · derivative.exercise_date: The RSUs were granted on the Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.

F3 · derivative.expiration_date: The RSUs were granted on the Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.

Read SEC document
February 13, 2024 Filed Feb 16, 2024 16:28 UTC
Howton David TChief Operating Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 117,500 $0.00 Strike: $7.85 $0.00
Disclosure

SEC source: 0000950170-24-016193 · ownership.xml · derivative · entry 1

Howton David T · CIK 0001529297 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 117,500

Underlying: Common Stock · 117,500 shares

Expires 2034-02-13

F1 · derivative.exercise_date: This option was granted on February 13, 2024 (the "Grant Date") and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the Grant Date and 2.0833% of the original number of shares monthly thereafter until the fourth such anniversary.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.